Loading
Latest filing published 14 Aug 2020 for HEAT BIOLOGICS, INC., €6,876.
William L. Ostrander appears in our data through filings on Heat Biologics, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated 13 August 2020.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 14 August 2020, reports an option exercise of €6,876 in Heat Biologics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations